Evotec SE (EVO) Receivables (2009 - 2026)
Evotec SE's (EVO) quarterly Receivables came in at $150.7 million in Q2 2026, down 0.67% year-over-year from $151.7 million in Q2 2025, and down 3.65% quarter-over-quarter from $156.4 million in Q1 2026.
Analysis
Evotec SE (EVO) Receivables (2009 - 2026) Analysis & Trends
Evotec SE has disclosed Receivables across 9 years of filings, most recently posting $150.7 million for Q2 2026.
- In Q2 2026, Receivables fell 0.67% year-over-year to $150.7 million; the TTM figure through Jun 2026 stood at $150.7 million (down 0.67% YoY), while the FY2025 annual figure was $185.6 million, up 5.61% from the prior year.
- Receivables came in at $150.7 million for Q2 2026 at Evotec SE, down from $156.4 million in the prior quarter.
- In the past five years, Receivables ranged from a high of $249.3 million in Q2 2023 to a low of $126.4 million in Q1 2022.
- Average Receivables over 5 years is $169.3 million, with a median of $156.4 million recorded in 2026.
- The largest YoY upside for Receivables was 84.43% in 2023 against a maximum downside of 35.68% in 2023.
- Over 5 years, Receivables stood at $206.4 million in 2022, then slumped by 35.68% to $132.8 million in 2023, then jumped by 30.67% to $173.5 million in 2024, then grew by 10.21% to $191.2 million in 2025, then fell by 21.19% to $150.7 million in 2026.
- Per Business Quant data, the three most recent Receivables figures were $150.7 million in Q2 2026, $156.4 million in Q1 2026, and $191.2 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.06 Bn | 42.11 Bn | 1.44 Bn | 5.16 Bn |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn | 463.06 Mn |
| 3 | Charles River Laboratories International | 13.77 Bn | 13.62 Bn | 452.07 Mn | 720.47 Mn |
| 4 | Icon | 12.62 Bn | 11.69 Bn | 479.29 Mn | 2.51 Bn |
| 5 | Fortrea Holdings | 1.68 Bn | 1.51 Bn | 139.20 Mn | 654.40 Mn |
| 6 | Evotec SE | 661.34 Mn | 235.46 Mn | - | 150.69 Mn |
| 7 | Ginkgo Bioworks Holdings | 442.79 Mn | 358.26 Mn | 18.44 Mn | 20.41 Mn |
| 8 | Champions Oncology | 72.49 Mn | 72.62 Mn | 7.03 Mn | 21.76 Mn |
| 9 | MindWalk Holdings | 61.66 Mn | 53.38 Mn | 1.82 Mn | 2.27 Mn |
| 10 | VivoSim Labs | 1.47 Mn | 1.47 Mn | - | 29,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 150.69 Mn |
| Mar 31, 2026 | 156.39 Mn |
| Dec 31, 2025 | 191.20 Mn |
| Sep 30, 2025 | 182.00 Mn |
| Jun 30, 2025 | 151.71 Mn |
| Mar 31, 2025 | 232.69 Mn |
| Dec 31, 2024 | 173.49 Mn |
| Sep 30, 2024 | 150.27 Mn |
| Mar 31, 2024 | 159.19 Mn |
| Dec 31, 2023 | 132.77 Mn |
| Jun 30, 2023 | 249.31 Mn |
| Dec 31, 2022 | 206.41 Mn |
| Sep 30, 2022 | 141.79 Mn |
| Jun 30, 2022 | 135.18 Mn |
| Mar 31, 2022 | 126.39 Mn |
| Dec 31, 2021 | 172.39 Mn |
| Sep 30, 2021 | 131.49 Mn |
| Dec 31, 2020 | 58.53 Mn |
| Sep 30, 2010 | 6.36 Mn |
| Jun 30, 2010 | 8.70 Mn |